Literature DB >> 3917934

Partial purification of a factor from human synovium that possesses interleukin 1, chondrocyte stimulating and catabolin-like activities.

P R Elford, J E Meats, R M Sharrard, R G Russell.   

Abstract

Human synovial explants in culture release material that stimulates the production of prostaglandin E2 (PGE2) and several extracellular enzymes by human chondrocytes. Fractionation of conditioned medium by gel filtration revealed a protein of approx. 15 kDa, which in addition to stimulating production of PGE2 and plasminogen activator by human articular chondrocytes, possessed interleukin 1 activity and induced cartilage degradation. Further purification using iso-electric focussing again showed co-elution of these activities with a major pI of 6.9 and a minor pI of 5.1-5.3. This study indicated that human synovium releases a factor that is closely related to or identical with interleukin 1 and suggests that this protein may participate in cellular interactions that occur within the rheumatoid joint.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917934     DOI: 10.1016/0014-5793(85)80528-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  The effect of anti-rheumatic drugs on factors from porcine synovium inducing chondrocyte mediated cartilage degradation.

Authors:  K G Couchman; H Sheppeard
Journal:  Agents Actions       Date:  1986-10

Review 2.  What's happened to catabolin?

Authors:  H Sheppeard; K G Couchman
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

3.  Cycloheximide inhibits the induction of collagenase mRNA in chondrocytes exposed to synovial factors or recombinant interleukin-1.

Authors:  C W Lin; H I Georgescu; S L Phillips; C H Evans
Journal:  Agents Actions       Date:  1989-06

4.  Differential responses of old human cartilage explants to synovial- and mononuclear-cell factors.

Authors:  O Huber-Bruning; B Wilbrink; J E Vernooij; J W Bijlsma; W den Otter; J Huber
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.